Patents by Inventor David Gurley

David Gurley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Positive modulators of nicotinic receptor agonists
    Patent number: 7402604
    Abstract: Compounds according to formula I: wherein R1, W, R2, R3, X, R4 and R5 are as described in the specification, enantiomers thereof, pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially for treatment of conditions associated with reductions in nicotinic transmission.
    Type: Grant
    Filed: July 11, 2005
    Date of Patent: July 22, 2008
    Assignee: AstraZeneca AB
    Inventors: David Gurley, James Rosamond
  • Positive modulators of nicotinic receptor agonists
    Patent number: 7064143
    Abstract: Compounds of Formula I wherein R1, R2, R3, R4, R5, W and X as defined in the specification, enantiomers thereof, pharmaceutically-acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially for treatment of conditions associated with reductions in nicotinic transmission. Compounds of the invention enhance the efficacy of agonists at nicotinic receptors.
    Type: Grant
    Filed: November 1, 2000
    Date of Patent: June 20, 2006
    Assignee: AstraZeneca AB
    Inventors: David Gurley, James Rosamond
  • Positive modulators of nicotinic receptor agonists
    Publication number: 20050245595
    Abstract: Compounds according to formula I: wherein R1, W, R2, R3, X, R4 and R5 are as described in the specification, enantiomers thereof, pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially for treatment of conditions associated with reductions in nicotinic transmission.
    Type: Application
    Filed: July 11, 2005
    Publication date: November 3, 2005
    Inventors: David Gurley, James Rosamond
  • Positive modulators of nicotinic receptors
    Patent number: 6861443
    Abstract: The present invention relates to pharmaceutical compositions comprising a positive modulator of a nicotinic receptor agonist, said positive modulator having the capability to increase the efficacy of the said nicotinic receptor agonist.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: March 1, 2005
    Assignee: Astra AB
    Inventors: David Gurley, Thomas Lanthorn
  • Treatment of fibromyalgia syndrome
    Publication number: 20040259909
    Abstract: A method for treating fibromyalgia syndrome with an agonist of &agr;7 nicotinic acetylcholine receptors.
    Type: Application
    Filed: April 16, 2004
    Publication date: December 23, 2004
    Inventors: Dennis McCarthy, David Gurley
  • Positive modulators of nicotinic receptor agonists
    Patent number: 6756398
    Abstract: Compounds of Formula I wherein R1a, R1b, R2b, R3b, R3a, R2a, B1, B2, Z, A2 and A1 are as defined in the specification, enantiomers thereof, pharmaceutically-acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially for treatment of conditions associated with reductions in nicotinic transmission. Compounds of the invention enhance the efficacy of agonists at nicotinic receptors.
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: June 29, 2004
    Assignee: Astrazeneca AB
    Inventors: Michael Balestra, David Gurley, James Rosamond
  • Positive modulators of nicotinic receptor agonists
    Patent number: 6750242
    Abstract: Compounds of Formula I wherein R1, R2, R3 and R4 are as defined in the specification, enantiomers thereof, pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially for treatment of conditions associated with reductions in nicotinic transmission. The compounds of the invention enhance the efficacy of agonists at nicotinic receptors.
    Type: Grant
    Filed: September 23, 2002
    Date of Patent: June 15, 2004
    Assignee: AstraZeneca AB
    Inventors: David Gurley, Thomas Lanthorn, John Macor, James Rosamond
  • Use
    Publication number: 20010041732
    Abstract: The present invention relates to pharmaceutical compositions comprising a positive modulator of a nicotinic receptor agonist, said positive modulator having the capability to increase the efficacy of the said nicotinic receptor agonist.
    Type: Application
    Filed: March 20, 2001
    Publication date: November 15, 2001
    Inventors: David Gurley, Thomas Lanthorn
  • Use
    Patent number: 6277870
    Abstract: The present invention relates to pharmaceutical compositions comprising a positive modulator of a nicotinic receptor agonist, said positive modulator having the capability to increase the efficacy of the said nicotinic receptor agonist.
    Type: Grant
    Filed: May 4, 1998
    Date of Patent: August 21, 2001
    Assignee: Astra AB
    Inventors: David Gurley, Thomas Lanthorn
  • Oral care implement package
    Patent number: D704548
    Type: Grant
    Filed: August 7, 2013
    Date of Patent: May 13, 2014
    Assignee: Colgate-Palmolive Company
    Inventors: David Demar, David Gurley, Robert Moskovich, Alan Sorrentino, Francisco Dondo
  • Oral care implement package
    Patent number: D714635
    Type: Grant
    Filed: March 26, 2014
    Date of Patent: October 7, 2014
    Assignee: Colgate-Palmolive Company
    Inventors: David Demar, David Gurley, Robert Moskovich, Alan Sorrentino, Francisco Dondo